Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Canada Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20034
20046
20055
20066
20076
20088
20093
20107
20116
201211
20131
20144
20157
20169
20179
20185
20196
202017
202110
20225
20232
20244
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Terminated20
Active, not recruiting18
Recruiting11
Unknown status7
Withdrawn3
No longer available2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb12
Merck Sharp & Dohme LLC11
Novartis Pharmaceuticals11
Pfizer11
University Health Network, Toronto11
National Cancer Institute (NCI)10
Hoffmann-La Roche5
Sunnybrook Health Sciences Centre5
Argos Therapeutics4
AstraZeneca4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell157
Kidney Neoplasms34
Carcinoma, Non-Small-Cell Lung24
Melanoma23
Neoplasm Metastasis18
Neoplasms15
Squamous Cell Carcinoma of Head and Neck13
Colorectal Neoplasms12
Ovarian Neoplasms10
Triple Negative Breast Neoplasms10

Trials

Showing 26 to 50 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.